The mechanisms of prion disease

CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources

Volumn 6, Issue , 2011, Pages

  Gill, Andrew C ^a   Lane, Fiona M ^a   Alibhai, James ^a   Manson, Jean C ^a   McCutcheon, Sandra ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Disease transmission; Neu rodegeneration; Neurotoxicity; Prion strains; Protein misfolding; Transmissible spongiform encephalopathies

Indexed keywords

BOVINAE; CERVIDAE; MAMMALIA; OVIS ARIES;

EID: 84857874627     PISSN: None     EISSN: 17498848     Source Type: Journal    
DOI: 10.1079/PAVSNNR20116055     Document Type: Review

References (459)

1. Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, et al. Transmissions to mice indicate that new variant' CJD is caused by the BSE agent. Nature 1997;389(6650):498-501. (Pubitemid 27435325)
2. www.eurocjd.ed.ac.uk. Data obtained Aug 2011.
3. Prusiner SB. Prions. Proceedings of the National Academy of Sciences of the United States of America 1998;95(23): 13363-83. (Pubitemid 28525623)
4. Stevenson MA, Wilesmith JW, Ryan JBM, Morris RS, Lockhart JW, Lin D, et al. Temporal aspects of the epidemic of bovine spongiform encephalopathy in Great Britain: individual animal-associated risk factors for the disease. Veterinary Record 2000;147(13):349-54.
5. Wilesmith JW, Ryan JBM, Stevenson MA, Morris RS, Pfeiffer DU, Lin D, et al. Temporal aspects of the epidemic of bovine spongiform encephalopathy in Great Britain: holding-associated risk factors for the disease. Veterinary Record 2000;147(12):319-25.
6. Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, et al. Mice devoid of PrP are resistant to scrapie. Cell 1993;73(7):1339-47. (Pubitemid 23201147)
7. Manson JC, Clarke AR, McBride PA, McConnell I, Hope J. PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. Neurodegeneration 1994;3(4):331-40.
8. Diringer H, Beekes M, Oberdieck U. The nature of the scrapie agent - the virus theory. Slow Infections of the Central Nervous System 1994;724:246-58. (Pubitemid 24223728)
9. Adams DH. Scrapie agent - small deoxyribonucleic acid-mediated virus. Biochemical Journal 1972;127(5):P82.
10. Hunter GD. Nature of scrapie virus. Pathologie-Biologie 1973;21(3):282-3.
11. Adams DH, Caspary EA. Nature of scrapie virus. British Medical Journal 1967;3(5558):173.
12. Hope J. The nature of the scrapie agent - the evolution of the virino. Slow Infections of the Central Nervous System 1994;724:282-9. (Pubitemid 24223730)
13. Kimberlin RH. Scrapie agent - prions or virinos. Nature 1982;297(5862):107-8.
14. Diener TO. Is scrapie agent a viroid. Nature-New Biology 1972;235(59):218.
15. Marx JL. Scrapie agent - is it a viroid. Science 1979;203(4380):532.
16. Manuelidis L, Yu ZX, Banquero N, Mullins B. Cells infected with scrapie and Creutzfeldt-Jakob disease agents produce intracellular 25-nm virus-like particles. Proceedings of the National Academy of Sciences of the United States of America 2007;104(6):1965-70. (Pubitemid 46239887)
17. Ozel M, Diringer H. Small virus-like structure in fractions from scrapie hamster brain. Lancet 1994;343(8902):894-5. (Pubitemid 24113634)
18. Manuelidis L. A 25 nm virion is the likely cause of transmissible spongiform encephalopathies. Journal of Cellular Biochemistry 2007;100(4):897-915.
19. Manuelidis L. Nuclease resistant circular DNAs copurify with infectivity in scrapie and CJD. Journal of Neurovirology 2011;17(2):131-45.
20. Dron M, Manuelidis L. Visualization of viral candidate cDNAs in infectious brain fractions from Creutzfeldt-Jakob disease by representational difference analysis. Journal of Neurovirology 1996;2(4):240-8. (Pubitemid 26285268)
21. Akowitz A, Sklaviadis T, Manuelidis L. Endogenous viral complexes with long RNA cosediment with the agent of Creutzfeldt-Jakob-disease. Nucleic Acids Research 1994;22(6):1101-7. (Pubitemid 24162176)
22. Akowitz A, Manuelidis EE, Manuelidis L. Protected endogenous retroviral sequences copurify with infectivity in experimental Creutzfeldt-Jakob-Disease. Archives of Virology 1993;130(3-4):301-16.
23. Desch B, Groth DF, Prusiner SB, Weissmann C. Search for a scrapie-specific nucleic-acid -a progress report. Ciba F Symposium 1988;135:209-23.
24. Aiken JM, Marsh RF. The search for scrapie agent nucleic-acid. Microbiology Reviews 1990;54(3):242-6.
25. Simoneau S, Ruchoux M-M, Vignier N, Lebon P, Freire S, Comoy E, et al. Small critical RNAs in the scrapie agent. Available from Nature Precedings, 2009. available at: URL: http://hdlhandlenet/10101/npre200933441.
26. Meyer N, Rosenbaum V, Schmidt B, Gilles K, Mirenda C, Groth D, et al. Search for a putative scrapie genome in purified prion fractions reveals a paucity of nucleic-acids. Journal of General Virology 1991;72:37-49.
27. Calzolai L, Lysek DA, Perez DR, Guntert P, Wuthrich K. Prion protein NMR structures of chickens, turtles, and frogs. Proceedings of the National Academy of Sciences of the United States of America 2005;102(3):651-5. (Pubitemid 40282720)
28. Christen B, Perez DR, Hornemann S, Wuthrich K. NMR structure of the bank vole prion protein at 20 degrees C contains a structured loop of residues 165-171. Journal of Molecular Biology 2008;383(2):306-12.
29. Gossert AD, Bonjour S, Lysek DA, Fiorito F, Wuthrich K. Prion protein NMR structures of elk and of mouse/elk hybrids. Proceedings of the National Academy of Sciences of the United States of America 2005;102(3):646-50. (Pubitemid 40282719)
30. Lysek DA, Schorn C, Nivon LG, Esteve-Moya V, Christen B, Calzolai L, et al. Prion protein NMR structures of cats, dogs, pigs, and sheep. Proceedings of the National Academy of Sciences of the United States of America 2005;102(3):640-5. (Pubitemid 40282718)
31. Perez DR, Damberger FF, Wuthrich K. Horse prion protein NMR structure and comparisons with related variants of the mouse prion protein. Journal of Molecular Biology 2010;400(2):121-8.
32. Wuthrich K, Riek R. Three-dimensional structures of prion proteins. Advances in Protein Chemistry 2001;57:55-82. (Pubitemid 32622680)
33. Eghiaian F, Grosclaude J, Lesceu S, Debey P, Doublet B, Treguer E, et al. Insight into the PrPC - PrPSc conversion from the structures of antibody-bound ovine prion scrapiesusceptibility variants. Proceedings of the National Academy of Sciences of the United States of America 2004;101(28):10254-9. (Pubitemid 38924912)
34. Haire LF, Whyte SM, Vasisht N, Gill AC, Verma C, Dodson EJ, et al. The crystal structure of the globular domain of sheep prion protein. Journal of Molecular Biology 2004;336(5):1175-83. (Pubitemid 38229705)
35. Antonyuk SV, Trevitt CR, Strange RW, Jackson GS, Sangar D, Batchelor M, et al. Crystal structure of human prion protein bound to a therapeutic antibody. Proceedings of the National Academy of Sciences of the United States of America 2009;106(8):2554-8.
36. Knaus KJ, Morillas M, Swietnicki W, Malone M, Surewicz WK, Yee VC. Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nature Structural Biology 2001;8(9):770-4. (Pubitemid 32803594)
37. Lee S, Antony L, Hartmann R, Knaus KJ, Surewicz K, Surewicz WK, et al. Conformational diversity in prion protein variants influences intermolecular beta-sheet formation. EMBO Journal 2010;29(1):251-62.
38. Khan MQ, Sweeting B, Mulligan VK, Ars lan PE, Cashman NR, Pai EF, et al. Prion disease susceptibility is affected by beta-structure folding propensity and local side-chain interactions in PrP. Proceedings of the National Academy of Sciences of the United States of America 2010;107(46):19808-13.
39. Hornemann S, Schorn C, Wuthrich K. NMR structure of the bovine prion protein isolated from healthy calf brains. EMBO Reports 2004;5(12):1159-64. (Pubitemid 40103610)
40. Nadal RC, Davies P, Brown DR, Viles JH. Evaluation of copper affinities for the prion protein. Biochemistry 2009;48(38):8929-31.
41. Pauly PC, Harris DA. Copper stimulates endocytosis of the prion protein. Journal of Biological Chemistry 1998;273(50):33107-10. (Pubitemid 29005676)
42. Whittal RM, Ball HL, Cohen FE, Burlingame AL, Prusiner SB, Baldwin MA. Copper binding to octarepeat peptides of the prion protein monitored by mass spectrometry. Protein Science 2000;9(2):332-43. (Pubitemid 30127006)
43. Wong BS, Venien-Bryan C, Williamson RA, Burton DR, Gambetti P, Sy MS, et al. Copper refolding of prion protein. Biochemical and Biophysical Research Communications 2000;276(3):1217-24.
44. Brown DR, Qin K, Herms JW, Mad lung A, Manson J, Strome R, et al. The cellular prion protein binds copper in vivo. Nature 1997;390(6661):684-7. (Pubitemid 28016355)
45. Waggoner DJ, Drisaldi B, Bartnikas TB, Casareno RL, Prohaska JR, Gitlin JD, et al. Brain copper content and cuproenzyme activity do not vary with prion protein expression level. Journal of Biological Chemistry 2000;275(11):7455-8. (Pubitemid 30159637)
46. Brimacombe DB, Bennett AD, Wusteman FS, Gill AC, Dann JC, Bostock CJ. Characterization and polyanionbinding properties of purified recombinant prion protein. Biochemical Journal 1999;342(3):605-13. (Pubitemid 29452645)
47. Blanch EW, Gill AC, Rhie AG, Hope J, Hecht L, Nielsen K, et al. Raman optical activity demonstrates poly(I-proline) II helix in the N-terminal region of the ovine prion protein: implications for function and misfunction. Journal of Molecular Biology 2004;343(2):467-76. (Pubitemid 39296879)
48. Gill AC, Ritchie MA, Hunt LG, Steane SE, Davies KG, Bocking SP, et al. Post-translational hydroxylation at the N-terminus of the prion protein reveals presence of PPII structure in vivo. EMBO Journal 2000;19(20):5324-31.
49. Taubner LM, Bienkiewicz EA, Copie V, Caughey B. Structure of the flexible amino-terminal domain of prion protein bound to a sulfated glycan. Journal of Molecular Biology 2010;395(3):475-90.
50. Hope J, Morton LJ, Farquhar CF, Multhaup G, Beyreuther K, Kimberlin RH. The major polypeptide of scrapie-associated fibrils (SAF) has the same size, charge distribution and N-terminal protein sequence as predicted for the normal brain protein (PrP). EMBO Journal 1986;5(10):2591-7.
51. Fischer M, Rulicke T, Raeber A, Sailer A, Moser M, Desch B, et al. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO Journal 1996;15(6):1255-64. (Pubitemid 26093461)
52. Stahl N, Baldwin MA, Hecker R, Pan KM, Burlingame AL, Prusiner SB. Glycosylinositol phospholipid anchors of the scrapie and cellular prion proteins contain sialic acid. Biochemistry 1992;31(21):5043-53.
53. Stahl N, Baldwin MA, Teplow DB, Hood L, Gibson BW, Burlingame AL, et al. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry 1993;32(8):1991-2002. (Pubitemid 23086050)
54. Caughey BW, Dong A, Bhat KS, Ernst D, Hayes SF, Caughey WS. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 1991;30(31):7672-80.
55. Guest WC, Plotkin SS, Cashman NR. Toward a mechanism of prion misfolding and structural models of PrP(Sc): current knowledge and future directions. Journal of Toxicology and Environmental Health. Part A 2011;74(2-4):154-60.
56. Peretz D, Williamson RA, Matsunaga Y, Serban H, Pinilla C, Bastidas RB, et al. A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. Journal of Molecular Biology 1997;273(3):614-22. (Pubitemid 27488803)
57. Wille H, Michelitsch MD, Guenebaut V, Supattapone S, Serban A, Cohen FE, et al. Structural studies of the scrapie prion protein by electron crystallography. Proceedings of the National Academy of Sciences of the United States of America 2002;99(6):3563-8. (Pubitemid 34252147)
58. Govaerts C, Wille H, Prusiner SB, Cohen FE. Evidence for assembly of prions with left-handed beta-helices into trimers. Proceedings of the National Academy of Sciences of the United States of America 2004;101(22):8342-7. (Pubitemid 38736577)
59. DeMarco ML, Daggett V. From conversion to aggregation: protofibril formation of the prion protein. Proceedings of the National Academy of Sciences of the United States of America 2004;101(8):2293-8. (Pubitemid 38269305)
60. Daggett V. Alpha-sheet: the toxic conformer in amyloid diseases? Accounts of Chemical Research 2006;39(9): 594-602.
61. DeMarco ML, Silveira J, Caughey B, Daggett V. Structural properties of prion protein protofibrils and fibrils: an experimental assessment of atomic models. Biochemistry 2006;45(51):15573-82. (Pubitemid 46032478)
62. Smirnovas V, Baron GS, Offerdahl DK, Raymond GJ, Caughey B, Surewicz WK. Structural organization of brain-derived mammalian prions examined by hydrogen-deuterium exchange. Nature Structural and Molecular Biology 2011;18(4):504-6.
63. Cobb NJ, Apetri AC, Surewicz WK. Prion protein amyloid formation under native-like conditions involves refolding of the C-terminal alpha-helical domain. Journal of Biological Chemistry 2008;283(50):34704-11.
64. Cobb NJ, Sonnichsen FD, Mchaourab H, Surewicz WK. Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure. Proceedings of the National Academy of Sciences of the United States of America 2007;104(48):18946-51.
65. Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond GJ, Lansbury PT, et al. Cell-free formation of protease-resistant prion protein. Nature 1994;370(6489):471-4. (Pubitemid 24263553)
66. Kirby L, Birkett CR, Rudyk H, Gilbert IH, Hope J. In vitro cell-free conversion of bacterial recombinant PrP to PrPres as a model for conversion. Journal of General Virology 2003;84(4):1013-20. (Pubitemid 36432234)
67. Kocisko DA, Priola SA, Raymond GJ, Chesebro B, Lansbury Jr PT, Caughey B. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier. Proceedings of the National Academy of Sciences of the United States of America 1995;92(9):3923-7.
68. Caughey WS, Raymond LD, Horiuchi M, Caughey B. Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines. Proceedings of the National Academy of Sciences of the United States of America 1998;95(21):12117-22. (Pubitemid 28483728)
69. Demaimay R, Chesebro B, Caughey B. Inhibition of formation of protease-resistant prion protein by Trypan Blue, Sirius Red and other Congo Red analogs. Archives of Virology, Supplement 2000(16):277-83. (Pubitemid 33757386)
70. Demaimay R, Harper J, Gordon H, Weaver D, Chesebro B, Caughey B. Structural aspects of Congo red as an inhibitor of protease-resistant prion protein formation. Journal of Neurochemistry 1998;71(6):2534-41. (Pubitemid 28531265)
71. Horiuchi M, Caughey B. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state. EMBO Journal 1999;18(12):3193-203. (Pubitemid 29276566)
72. Bossers A, Belt P, Raymond GJ, Caughey B, de Vries R, Smits MA. Scrapie susceptibility-linked polymorphisms modulate the in vitro conversion of sheep prion protein to protease-resistant forms. Proceedings of the National Academy of Sciences of the United States of America 1997;94(10):4931-6. (Pubitemid 27214713)
73. Eiden M, Soto EO, Mettenleiter TC, Groschup MH. Effects of polymorphisms in ovine and caprine prion protein alleles on cell-free conversion. Veterinary Research 2011;42(1):30.
74. Kirby L, Agarwal S, Graham JF, Goldmann W, Gill AC. Inverse correlation of thermal lability and conversion efficiency for five prion protein polymorphic variants. Biochemistry 2010;49(7):1448-59.
75. Kirby L, Goldmann W, Houston F, Gill AC, Manson JC. A novel, resistance-linked ovine PrP variant and its equivalent mouse variant modulate the in vitro cell-free conversion of rPrP to PrP(res). Journal of General Virology 2006;87(12):3747-51. (Pubitemid 44817011)
76. Baron GS, Wehrly K, Dorward DW, Chesebro B, Caughey B. Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrP(Sc)) into contiguous membranes. EMBO Journal 2002;21(5):1031-40. (Pubitemid 34206176)
77. Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001;411(6839):810-3. (Pubitemid 32588105)
78. Castilla J, Saa P, Soto C. Detection of prions in blood. Nature Medicine 2005;11(9):982-5. (Pubitemid 41294444)
79. Saa P, Castilla J, Soto C. Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. Journal of Biological Chemistry 2006;281(46):35245-52. (Pubitemid 46036562)
80. Castilla J, Saa P, Hetz C, Soto C. In vitro generation of infectious scrapie prions. Cell 2005;121(2):195-206. (Pubitemid 40546388)
81. Barria MA, Mukherjee A, Gonzalez-Romero D, Morales R, Soto C. De novo generation of infectious prions in vitro produces a new disease phenotype. PLoS Pathogen 2009;5(5):e1000421.
82. Deleault NR, Harris BT, Rees JR, Supattapone S. Formation of native prions from minimal components in vitro . Proceedings of the National Academy of Sciences of the United States of America 2007;104(23):9741-6. (Pubitemid 47175337)
83. Colby DW, Zhang Q, Wang S, Groth D, Legname G, Riesner D, et al. Prion detection by an amyloid seeding assay. Proceedings of the National Academy of Sciences of the United States of America 2007;104(52):20914-9.
84. Atarashi R, Wilham JM, Christensen L, Hughson AG, Moore RA, Johnson LM, et al. Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nature Methods 2008;5(3):211-2. (Pubitemid 351325633)
85. Safar JG, DeArmond SJ, Kociuba K, Deering C, Didorenko S, Bouzamondo-Bernstein E, et al. Prion clearance in bigenic mice. Journal of General Virology 2005;86(Pt 10):2913-23. (Pubitemid 41410483)
86. Masel J, Jansen VA, Nowak MA. Quantifying the kinetic parameters of prion replication. Biophysical Chemistry 1999;77(2-3):139-52. (Pubitemid 29206647)
87. Wang F, Wang X, Yuan CG, Ma J. Generating a prion with bacterially expressed recombinant prion protein. Science 2010;327(5969):1132-5.
88. Baskakov IV, Legname G, Baldwin MA, Prusiner SB, Cohen FE. Pathway complexity of prion protein assembly into amyloid. Journal of Biological Chemistry 2002;277(24):21140-8. (Pubitemid 34952249)
89. StohrJ, Elfrink K, Weinmann N, Wille H, Willbold D, Birkmann E, et al. In vitro conversion and seeded fibrillization of posttranslationally modified prion protein. Biological Chemistry 2011;392(5):415-21.
90. Rezaei H. Prion protein oligomerization. Current Alzheimer Research 2008;5(6):572-8.
91. Tahiri-Alaoui A, Gill AC, Disterer P, James W. Methionine 129 variant of human prion protein oligomerizes more rapidly than the valine 129 variant: implications for disease susceptibility to Creutzfeldt-Jakob disease. Journal of Biological Chemistry 2004;279(30):31390-7. (Pubitemid 39037806)
92. Tahiri-Alaoui A, Sim VL, Caughey B, James W. Molecular heterosis of prion protein beta-oligomers. A potential mechanism of human resistance to disease. Journal of Biological Chemistry 2006;281(45):34171-8. (Pubitemid 46036625)
93. Makarava N, Lee CI, Ostapchenko VG, Baskakov IV. Highly promiscuous nature of prion polymerization. Journal of Biological Chemistry 2007;282(50):36704-13.
94. Baskakov I, Disterer P, Breydo L, Shaw M, Gill A, James W, et al. The presence of valine at residue 129 in human prion protein accelerates amyloid formation. FEBS Lett 2005;579(12):2589-96. (Pubitemid 40615663)
95. Legname G, Baskakov IV, Nguyen HO, Riesner D, Cohen FE, DeArmond SJ, et al. Synthetic mammalian prions. Science 2004;305(5684):673-6. (Pubitemid 39006757)
96. Makarava N, Kovacs GG, Bocharova O, Savtchenko R, Alexeeva I, Budka H, et al. Recombinant prion protein induces a new transmissible prion disease in wild-type animals. Acta Neuropathologica 2010;119(2):177-87.
97. Birkmann E, Riesner D. Prion infection: seeded fibrillization or more? Prion 2008;2(2):67-72.
98. Gill AC, Agarwal S, Pinheiro TJ, Graham JF. Structural requirements for efficient prion protein conversion: cofactors may promote a conversion-competent structure for PrP(C). Prion 2010;4(4):235-42.
99. Graham JF, Agarwal S, Kurian D, Kirby L, Pinheiro TJ, Gill AC. Low density subcellular fractions enhance disease-specific prion protein misfolding. Journal of Biological Chemistry 2010;285(13):9868-80.
100. Deleault NR, Geoghegan JC, Nishina K, Kascsak R, Williamson RA, Supattapone S. Protease-resistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions. Journal of Biological Chemistry 2005;280(29):26873-9. (Pubitemid 41040721)
101. Deleault NR, Lucassen RW, Supattapone S. RNA molecules stimulate prion protein conversion. Nature 2003;425(6959):717-20. (Pubitemid 37314314)
102. Edgeworth JA, Gros N, Alden J, Joiner S, Wadsworth JD, Linehan J, et al. Spontaneous generation of mammalian prions. Proceedings of the National Academy of Sciences of the United States of America 2010;107(32):14402-6.
103. Weber P, Giese A, Piening N, Mitteregger G, Thomzig A, Beekes M, et al. Generation of genuine prion infectivity by serial PMCA. Veterinary Microbiology 2007;123(4): 346-57. (Pubitemid 47096769)
104. Giorgi A, Di Francesco L, Principe S, Mignogna G, Sennels L, Mancone C, et al. Proteomic profiling of PrP27-30-enriched preparations extracted from the brain of hamsters with experimental scrapie. Proteomics 2009;9(15):3802-14.
105. Moore RA, Timmes A, Wilmarth PA, Priola SA. Comparative profiling of highly enriched 22L and Chandler mouse scrapie prion protein preparations. Proteomics 2010;10(15):2858-69.
106. Petrakis S, Malinowska A, Dadlez M, Sklaviadis T. Identification of proteins co-purifying with scrapie infectivity. Journal of Proteomics 2009;72(4):690-4.
107. Graham JF, Kurian D, Agarwal S, Toovey L, Hunt L, Kirby L, et al. Na +/K+ -ATPase is present in scrapie-associated fibrils, modulates PrP misfolding in vitro and links PrP function and dysfunction 2011;6(11): e26813.
108. Appel TR, Dumpitak C, Matthiesen U, Riesner D. Prion rods contain an inert polysaccharide scaffold. Biological Chemistry 1999;380(11):1295-306.
109. Dumpitak C, Beekes M, Weinmann N, Metzger S, Winklhofer KF, Tatzelt J, et al. The polysaccharide scaffold of PrP 27-30 is a common compound of natural prions and consists of alpha-linked polyglucose. Biological Chemistry 2005;386(11):1149-55. (Pubitemid 41705369)
110. Klein TR, Kirsch D, Kaufmann R, Riesner D. Prion rods contain small amounts of two host sphingolipids as revealed by thin-layer chromatography and mass spectrometry. Biological Chemistry 1998;379(6):655-66. (Pubitemid 28327564)
111. Lewis V, Hooper NM. The role of lipid rafts in prion protein biology. Frontiers in Bioscience 2011;16:151-68.
112. Naslaysky N, Stein R, Yanai A, Friedlander G, Taraboulos A. Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform. Journal of Biological Chemistry 1997;272(10):6324-31. (Pubitemid 27118107)
113. Hooper NM, Taylor DR, Watt NT. Mechanism of the metal-mediated endocytosis of the prion protein. Biochemical Society Transactions 2008;36(Pt 6):1272-6.
114. Shyng SL, Heuser JE, Harris DA. A glycolipid-anchored prion protein is endocytosed via clathrin-coated pits. Journal of Cell Biology 1994;125(6):1239-50. (Pubitemid 24189529)
115. Peters PJ, Mironov Jr A, Peretz D, van Donselaar E, Leclerc E, Erpel S, et al. Trafficking of prion proteins through a caveolae-mediated endosomal pathway. Journal of Cell Biology 2003;162(4):703-17. (Pubitemid 37022947)
116. Vey M, Pilkuhn S, Wille H, Nixon R, DeArmond SJ, Smart EJ, et al. Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proceedings of the National Academy of Sciences of the United States of America 1996;93(25):14945-9. (Pubitemid 26419075)
117. Shyng SL, Huber MT, Harris DA. A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells. Journal of Biological Chemistry 1993;268(21):15922-8. (Pubitemid 23222097)
118. Borchelt DR, Taraboulos A, Prusiner SB. Evidence for synthesis of scrapie prion proteins in the endocytic pathway. Journal of Biological Chemistry 1992;267(23):16188-99.
119. Hooper NM. Glypican-1 facilitates prion conversion in lipid rafts. Journal of Neurochemistry 2011;116(5):721-5.
120. Abid K, Morales R, Soto C. Cellular factors implicated in prion replication. FEBS Lett 2010;584(11):2409-14.
121. Taylor DR, Whitehouse IJ, Hooper NM. Glypican-1 mediates both prion protein lipid raft association and disease isoform formation. PLoS Pathogen 2009;5(11):e1000666.
122. Bujdoso R, Burke DF, Thackray AM. Structural differences between allelic variants of the ovine prion protein revealed by molecular dynamics simulations. Proteins 2005;61(4):840-9. (Pubitemid 41753154)
123. Paludi D, Thellung S, Chiovitti K, Corsaro A, Villa V, Russo C, et al. Different structural stability and toxicity of PrP(ARR) and PrP(ARQ) sheep prion protein variants. Journal of Neurochemistry 2007;103(6):2291-300. (Pubitemid 350173570)
124. Thackray AM, Yang S, Wong E, Fitzmaurice TJ, Morgan- Warren RJ, Bujdoso R. Conformational variation between allelic variants of cell-surface ovine prion protein. Biochemical Journal 2004;381(1):221-9. (Pubitemid 38932228)
125. Apetri AC, Surewicz K, Surewicz WK. The effect of disease-associated mutations on the folding pathway of human prion protein. Journal of Biological Chemistry 2004;279(17):18008-14. (Pubitemid 38560570)
126. Bae SH, Legname G, Serban A, Prusiner SB, Wright PE, Dyson HJ. Prion proteins with pathogenic and protective mutations show similar structure and dynamics. Biochemistry 2009;48(34):8120-8.
127. Inouye H, Bond J, Baldwin MA, Ball HL, Prusiner SB, Kirschner DA. Structural changes in a hydrophobic domain of the prion protein induced by hydration and by ala →Val and pro →Leu substitutions. Journal of Molecular Biology 2000;300(5):1283-96.
128. Rossetti G, Cong X, Caliandro R, Legname G, Carloni P. Common structural traits across pathogenic mutants of the human prion protein and their implications for familial prion diseases. Journal of Molecular Biology 2011;411(3):700-12.
129. van der Kamp MW, Daggett V. Pathogenic mutations in the hydrophobic core of the human prion protein can promote structural instability and misfolding. Journal of Molecular Biology 2010;404(4):732-48.
130. Vanik DL, Surewicz WK. Disease-associated F198S mutation increases the propensity of the recombinant prion protein for conformational conversion to scrapie-like form. Journal of Biological Chemistry 2002;277(50):49065-70. (Pubitemid 35470879)
131. Yin S, Pham N, Yu S, Li C, Wong P, Chang B, et al. Human prion proteins with pathogenic mutations share common conformational changes resulting in enhanced binding to glycosaminoglycans. Proceedings of the National Academy of Sciences of the United States of America 2007;104(18):7546-51. (Pubitemid 47185943)
132. Hafner-Bratkovic I, Bester R, Pristovsek P, Gaedtke L, Veranic P, Gaspersic J, et al. Globular domain of the prion protein needs to be unlocked by domain swapping to support prion protein conversion. Journal of Biological Chemistry 2011;286(14):12149-56.
133. Herrmann LM, Caughey B. The importance of the disulfide bond in prion protein conversion. Neuroreport 1998;9(11):2457-61. (Pubitemid 28387130)
134. Lucassen R, Nishina K, Supattapone S. In vitro amplification of protease-resistant prion protein requires free sulfhydryl groups. Biochemistry 2003;42(14):4127-35. (Pubitemid 36418306)
135. Welker E, Raymond LD, Scheraga HA, Caughey B. Intramolecular versus intermolecular disulfide bonds in prion proteins. Journal of Biological Chemistry 2002;277(36):33477-81. (Pubitemid 34984871)
136. Chesebro B, Trifilo M, Race R, Meade-White K, Teng C, LaCasse R, et al. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 2005;308(5727):1435-9. (Pubitemid 40791292)
137. Caughey B, Baron GS, Chesebro B, Jeffrey M. Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Annual Review of Biochemistry 2009;78:177-204.
138. Rudd PM, Merry AH, Wormald MR, Dwek RA. Glycosylation and prion protein. Current Opinion in Structural Biology 2002;12(5):578-86. (Pubitemid 35449064)
139. Priola SA, Lawson VA. Glycosylation influences crossspecies formation of protease-resistant prion protein. EMBO Journal 2001;20(23):6692-9. (Pubitemid 33134199)
140. Lehmann S, Harris DA. Blockade of glycosylation promotes acquisition of scrapie-like properties by the prion protein in cultured cells. Journal of Biological Chemistry 1997;272(34):21479-87. (Pubitemid 27374021)
141. Cancellotti E, Wiseman F, Tuzi NL, Baybutt H, Monaghan P, Aitchison L, et al. Altered glycosylated PrP proteins can have different neuronal trafficking in brain but do not acquire scrapie-like properties. Journal of Biological Chemistry 2005;280(52):42909-18. (Pubitemid 43049253)
142. DeArmond SJ, Sanchez H, Yehiely F, Qiu Y, Ninchak-Casey A, Daggett V, et al. Selective neuronal targeting in prion disease. Neuron 1997;19(6):1337-48. (Pubitemid 28030552)
143. Capellari S, Zaidi SI, Long AC, Kwon EE, Petersen RB. The Thr183Ala mutation, not the loss of the first glycosylation site, alters the physical properties of the prion protein. Journal of Alzheimer's Disease 2000;2(1):27-35. (Pubitemid 30353515)
144. Ikeda S, Kobayashi A, Kitamoto T. Thr but Asn of the N-glycosylation sites of PrP is indispensable for its misfolding. Biochemical and Biophysical Research Communications 2008;369(4):1195-8.
145. Salamat MK, Dron M, Chapuis J, Langevin C, Laude H. Prion propagation in cells expressing PrP glycosylation mutants. Journal of Virology 2011;85(7):3077-85.
146. Wong NK, Renouf DV, Lehmann S, Hounsell EF. Glycosylation of prions and its effects on protein conformation relevant to amino acid mutations. Journal of Molecular Graphics and Modelling 2000;18(2):126 -34, 63-5.
147. Neuendorf E, Weber A, Saalmueller A, Schatzl H, Reifenberg K, Pfaff E, et al. Glycosylation deficiency at either one of the two glycan attachment sites of cellular prion protein preserves susceptibility to bovine spongiform encephalopathy and scrapie infections. Journal of Biological Chemistry 2004;279(51):53306-16. (Pubitemid 40051835)
148. Tuzi NL, Cancellotti E, Baybutt H, Blackford L, Bradford B, Plinston C, et al. Host PrP glycosylation: a major factor determining the outcome of prion infection. PLoS Biology 2008;6(4):e100.
149. Nishina KA, Deleault NR, Mahal SP, Baskakov I, Luhrs T, Riek R, et al. The stoichiometry of host PrPC glycoforms modulates the efficiency of PrPSc formation in vitro . Biochemistry 2006;45(47):14129-39. (Pubitemid 44846202)
150. Piro JR, Harris BT, Nishina K, Soto C, Morales R, Rees JR, et al. Prion protein glycosylation is not required for strain-specific neurotropism. Journal of Virology 2009;83(11): 5321-8.
151. Cancellotti E, Bradford BM, Tuzi NL, Hickey RD, Brown D, Brown KL, et al. Glycosylation of PrPC determines timing of neuroinvasion and targeting in the brain following transmissible spongiform encephalopathy infection by a peripheral route. Journal of Virology 2010;84(7):3464-75.
152. Ritchie MA, Gill AC, Deery MJ, Lilley K. Precursor ion scanning for detection and structural characterization of heterogeneous glycopeptide mixtures. Journal of the American Society for Mass Spectrometry 2002;13(9): 1065-77. (Pubitemid 36871601)
153. Rudd PM, Endo T, Colominas C, Groth D, Wheeler SF, Harvey DJ, et al. Glycosylation differences between the normal and pathogenic prion protein isoforms. Proceedings of the National Academy of Sciences of the United States of America 1999;96(23):13044-9.
154. Stimson E, Hope J, Chong A, Burlingame AL. Site-specific characterization
155. Manson JC, Clarke AR, Hooper ML, Aitchison L, Mcconnell I, Hope J. 129/Ola mice carrying a null mutation in Prp that abolishes messenger-RNA production are developmentally normal. Molecular Neurobiology 1994;8(2-3):121-7.
156. Brandner S, Isenmann S, Raeber A, Fischer M, Sailer A, Kobayashi Y, et al. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 1996;379(6563): 339-43. (Pubitemid 26033075)
157. Barron RM, Campbell SL, King D, Bellon A, Chapman KE, Williamson RA, et al. High titers of transmissible spongiform encephalopathy infectivity associated with extremely low levels of PrPSc in vivo. Journal of Biological Chemistry 2007;282(49):35878-86. (Pubitemid 350277109)
158. Baumann F, Tolnay M, Brabeck C, Pahnke J, Kloz U, Niemann HH, et al. Lethal recessive myelin toxicity of prion protein lacking its central domain. EMBO Journal 2007;26(2):538-47. (Pubitemid 46160953)
159. Chiesa R, Piccardo P, Ghetti B, Harris DA. Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. Neuron 1998;21(6):1339-51. (Pubitemid 29022536)
160. Flechsig E, Hegyi I, Leimeroth R, Zuniga A, Rossi D, Cozzio A, et al. Expression of truncated PrP targeted to Purkinje cells of PrP knockout mice causes Purkinje cell death and ataxia. EMBO Journal 2003;22(12):3095-101. (Pubitemid 36758629)
161. Hegde RS, Mastrianni JA, Scott MR, DeFea KA, Tremblay P, Torchia M, et al. A transmembrane form of the prion protein in neurodegenerative disease. Science 1998;279(5352): 827-34. (Pubitemid 28106269)
162. Lasmezas CI, Deslys JP, Robain O, Jaegly A, Beringue V, Peyrin JM, et al. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 1997;275(5298):402-5. (Pubitemid 27051621)
163. Li A, Christensen HM, Stewart LR, Roth KA, Chiesa R, Harris DA. Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105-125. EMBO Journal 2007;26(2):548-58. (Pubitemid 46160954)
164. Ma J, Wollmann R, Lindquist S. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 2002;298(5599):1781-5. (Pubitemid 35404120)
165. Muramoto T, De Armond SJ, Scott M, Telling GC, Cohen FE, Prusiner SB. Heritable disorder resembling neuronal storage disease in mice expressing prion protein with deletion of an alpha-helix. Nature Medicine 1997;3(7):750-5. (Pubitemid 27298718)
166. Piccardo P, Manson JC, King D, Ghetti B, Barron RM. Accumulation of prion protein in the brain that is not associated with transmissible disease. Proceedings of the National Academy of Sciences of the United States of America 2007;104(11):4712-7. (Pubitemid 47186290)
167. Shmerling D, Hegyi I, Fischer M, Blattler T, Brandner S, Gotz J, et al. Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 1998;93(2):203-14. (Pubitemid 28180854)
168. Betmouni S, Deacon RMJ, Rawlins JNP, Ferry VH. Behavioral consequences of prion disease targeted to the hippocampus in a mouse model of scrapie. Psychobiology 1999;27(1):63-71. (Pubitemid 29207307)
169. Cunningham C, Deacon R, Wells H, Boche D, Waters S, Diniz CP, et al. Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease. European Journal of Neuroscience 2003;17(10):2147-55. (Pubitemid 36713975)
170. Guenther K, Deacon RM, Perry VH, Rawlins JN. Early behavioural changes in scrapie-affected mice and the influence of dapsone. European Journal of Neuroscience 2001;14(2):401-9. (Pubitemid 32777645)
171. Jeffrey M, Halliday WG, Bell J, Johnston AR, MacLeod NK, Ingham C, et al. Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie-infected murine hippocampus. Neuropathology and Applied Neurobiology 2000;26(1):41-54. (Pubitemid 30145305)
172. Cunningham C, Wilcockson DC, Campion S, Lunnon K, Perry VH. Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. Journal of Neuroscience 2005;25(40):9275-84. (Pubitemid 41500836)
173. Gray BC, Siskova Z, Perry VH, O'Connor V. Selective presynaptic degeneration in the synaptopathy associated with ME7-induced hippocampal pathology. Neurobiology of Disease 2009;35(1):63-74.
174. Chiti Z, Knutsen OM, Betmouni S, Greene JR. An integrated, temporal study of the behavioural, electrophysiological and neuropathological consequences of murine prion disease. Neurobiology of Disease 2006;22(2):363-73.
175. Siskova Z, Page A, O'Connor V, Perry VH. Degenerating synaptic boutons in prion disease: microglia activation without synaptic stripping. American Journal of Pathology 2009;175(4):1610-21.
176. Franklin SL, Love S, Greene JR, Betmouni S. Loss of Perineuronal Net in ME7 Prion Disease. Journal of Neuropathology and Experimental Neurology 2008;67(3):189-99. (Pubitemid 351483287)
177. Siso S, Puig B, Varea R, Vidal E, Acin C, Prinz M, et al. Abnormal synaptic protein expression and cell death in murine scrapie. Acta Neuropathologica 2002;103(6):615-26. (Pubitemid 36067510)
178. Betmouni S, Perry VH, Gordon JL. Evidence for an early inflammatory response in the central nervous system of mice with scrapie. Neuroscience 1996;74(1):1-5. (Pubitemid 26291142)
179. Wilhelmsson U, Bushong EA, Price DL, Smarr BL, Phung V, Terada M, et al. Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury. Proceedings of the National Academy of Sciences of the United States of America 2006;103(46):17513-8. (Pubitemid 44789000)
180. Butt AM, Colquhoun K, Tutton M, Berry M. Threedimensional morphology of astrocytes and oligodendrocytes in the intact mouse optic nerve. Journal of Neurocytology 1994;23(8):469-85. (Pubitemid 24246613)
181. Ransom B, Behar T, Nedergaard M. New roles for astrocytes (stars at last). Trends in Neurosciences 2003;26(10):520-2. (Pubitemid 37176905)
182. Robinson SR, Dreher Z. Evidence for three morphological classes of astrocyte in the adult rabbit retina: functional and developmental implications. Neuroscience Letters 1989;106(3):261-8. (Pubitemid 20008858)
183. Slezak M, Pfrieger FW. New roles for astrocytes: regulation of CNS synaptogenesis. Trends in Neurosciences 2003;26(10):531-5. (Pubitemid 37176907)
184. Chang Ling T, Stone J. Factors determining the morphology and distribution of astrocytes in the cat retina: a 'contact-spacing' model of astrocyte interaction. Journal of Comparative Neurology 1991;303(3):387-99.
185. Bushong EA, Marton ME, Ellisman MH. Maturation of astrocyte morphology and the establishment of astrocyte domains during postnatal hippocampal development. International Journal of Developmental Neuroscience 2004;22(2):73-86. (Pubitemid 38264165)
186. Grosche J, Matyash V, Moller T, Verkhratsky A, Reichenbach A, Kettenmann H. Microdomains for neuron-glia interaction: parallel fiber signaling to Bergmann glial cells. Nature Neuroscience 1999;2(2):139-43. (Pubitemid 30491313)
187. Araque A, Perea G, Navarrete M. Tripartite synapses: astrocytes process and control synaptic information. Trends in Neurosciences 2009;32(8):421-31.
188. Kreft M, Potokar M, Pangrsic T, Stenovec M, Zorec R. Properties of Regulated Exocytosis and Vesicle Trafficking in Astrocytes. Glia 2009;57(13):532.
189. Pekny M, Li LZ, Lundkvist A, Andersson D, Wilhelmsson U, Nagai N, et al. Protective role of reactive astrocytes in brain ischemia. Journal of Cerebral Blood Flow and Metabolism 2008;28(3):468-81. (Pubitemid 351304260)
190. Perry VH, Cunningham C, Boche D. Atypical inflammation in the central nervous system in prion disease. Current Opinion in Neurology 2002;15(3):349-54. (Pubitemid 34596901)
191. Perry VH, Cunningham C, Holmes C. Systemic infections and inflammation affect chronic neurodegeneration. Nature Reviews Immunology 2007;7(2):161-7. (Pubitemid 46174862)
192. Perry VH, Newman TA, Cunningham C. The impact of systemic infection on the progression of neurodegenerative disease. Nature Reviews. Neuroscience 2003;4(2):103-12. (Pubitemid 37271380)
193. Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nature Reviews. Neuroscience 2007;8(1):57-69. (Pubitemid 46011999)
194. Solito E, McArthur S, Cristante E, Paterno M, Christian H, Roncaroli F, et al. Annexin Al: a central player in the anti-inflammatory and neuroprotective role of microglia. Journal of Immunology 2010;185(10):6317-28.
195. Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 2002;416(6880):507-11. (Pubitemid 34288846)
196. Caughey B, Lansbury PT. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annual Review of Neuroscience 2003;26:267-98. (Pubitemid 37064935)
197. Simoneau S, Rezaei H, Sales N, Kaiser-Schulz G, Lefebvre-Roque M, Vidal C, et al. In vitro and in vivo neurotoxicity of prion protein oligomers. PLoS Pathogen 2007;3(8):e125.
198. Zhang C, Jackson AP, Zhang ZR, Han Y, Yu S, He RQ, et al. Amyloid-like aggregates of the yeast prion protein ure2 enter vertebrate cells by specific endocytotic pathways and induce apoptosis. PLoS One 2010;5(9):e12529.
199. Urbanc B, Cruz L, Le R, Sanders J, Ashe KH, Duff K, et al. Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 2002;99(22):13990-5. (Pubitemid 35257612)
200. Novitskaya V, Bocharova OV, Bronstein I, Baskakov IV. Amyloid fibrils of mammalian prion protein are highly toxic to cultured cells and primary neurons. Journal of Biological Chemistry 2006;281(19):13828-36. (Pubitemid 43855298)
201. Sanghera N, Wall M, Venien-Bryan C, Pinheiro TJ. Globular and pre-fibrillar prion aggregates are toxic to neuronal cells and perturb their electrophysiology. Biochimica et Biophysica Acta 2008;1784(6):873-81.
202. Kayed R, Sokolov Y, Edmonds B, McIntire TM, Milton SC, Hall JE, et al. Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. Journal of Biological Chemistry 2004;279(45):46363-6. (Pubitemid 39518276)
203. Quist A, Doudevski I, Lin H, Azimova R, Ng D, Frangione B, et al. Amyloid ion channels: a common structural link for protein-misfolding disease. Proceedings of the National Academy of Sciences of the United States of America 2005;102(30):10427-32. (Pubitemid 41061570)
204. Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, et al. The most infectious prion protein particles. Nature 2005;437(7056):257-61. (Pubitemid 41294488)
205. Tanaka M, Collins SR, Toyama BH, Weissman JS. The physical basis of how prion conformations determine strain phenotypes. Nature 2006;442(7102):585-9. (Pubitemid 44167919)
206. Martins IC, Kuperstein I, Wilkinson H, Maes E, Vanbrabant M, Jonckheere W, et al. Lipids revert inert Abeta amyloid fibrils to neurotoxic protofibrils that affect learning in mice. EMBO Journal 2008;27(1):224-33.
207. Bradford BM, Tuzi NL, Feltri ML, McCorquodale C, Cancellotti E, Manson JC. Dramatic reduction of PrPC level and glycosylation in peripheral nerves following PrP knock-out from Schwann cells does not prevent transmissible spongiform encephalopathy neuroinvasion. Journal of Neuroscience 2009;29(49):15445-54.
208. Manson JC, Jamieson E, Baybutt H, Tuzi NL, Barron R, McConnell I, et al. A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy. EMBO Journal 1999;18(23):6855-64.
209. Tuzi NL, Clarke AR, Bradford B, Aitchison L, Thomson V, Manson JC. Cre-loxP mediated control of PrP to study transmissible spongiform encephalopathy diseases. Genesis 2004;40(1):1-6. (Pubitemid 39655111)
210. Weissmann C. A 'unified theory' of prion propagation. Nature 1991;352(6337):679-83. (Pubitemid 21912402)
211. Bueler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 1992;356(6370):577-82.
212. Tobler I, Gaus SE, Deboer T, Achermann P, Fischer M, Rulicke T, et al. Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature 1996;380(6575): 639-42. (Pubitemid 26119019)
213. Curtis J, Errington M, Bliss T, Voss K, MacLeod N. Age-dependent loss of PTP and LTP in the hippocampus of PrP-null mice. Neurobiology of Disease 2003;13(1):55-62. (Pubitemid 36561598)
214. Maglio LE, Martins VR, Izquierdo I, Ramirez OA. Role of cellular prion protein on LTP expression in aged mice. Brain Research 2006;1097(1):11-8. (Pubitemid 44041290)
215. Miele G, Jeffrey M, Turnbull D, Manson J, Clinton M. Ablation of cellular prion protein expression affects mitochondria! numbers and morphology. Biochemical and Biophysical Research Communications 2002;291(2):372-7. (Pubitemid 34694415)
216. Brown DR, Wong BS, Hafiz F, Clive C, Haswell SJ, Jones IM. Normal prion protein has an activity like that of superoxide dismutase. Biochemical Journal 1999;344(1):1-5.
217. Graner E, Mercadante AF, Zanata SM, Forlenza OV, Cabral AL, Veiga SS, et al. Cellular prion protein binds laminin and mediates neuritogenesis. Brain Research. Molecular Brain Research 2000;76(1):85-92. (Pubitemid 30133236)
218. Lopes MH, Hajj GN, Muras AG, Mancini GL, Castro RM, Ribeiro KC, et al. Interaction of cellular prion and stress-inducible protein 1 promotes neuritogenesis and neuroprotection by distinct signaling pathways. Journal of Neuroscience 2005;25(49):11330-9. (Pubitemid 43083707)
219. + currents. Neuroscience Letters 1996;209(1):49-52.
220. 2+ homeostasis in hippocampal CA1 neurons. Journal of Neurochemistry 2006;98(6):1876-85. (Pubitemid 44298251)
221. Herms JW, Tings T, Dunker S, Kretzschmar HA. Prion protein affects Ca2+ -activated K+ currents in cerebellar purkinje cells. Neurobiology of Disease 2001;8(2):324-30. (Pubitemid 32382485)
222. Bremer J, Baumann F, Tiberi C, Wessig C, Fischer H, Schwarz P, et al. Axonal prion protein is required for peripheral myelin maintenance. Nature Neuroscience 2010;13(3):310-8.
223. Martins VR, Beraldo FH, Hajj GN, Lopes MH, Lee KS, Prado MA, et al. Prion protein: orchestrating neurotrophic activities. Current Issues in Molecular Biology 2010;12: 63-86.
224. Resenberger UK, Winklhofer KF, Tatzelt J. Neuroprotective and neurotoxic signaling by the prion protein. Topics in Current Chemistry 2011;Prion Proteins(305):101-19.
225. Mallucci G, Dickinson A, Linehan J, Klohn PC, Brandner S, Collinge J. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 2003;302(5646):871-4. (Pubitemid 37339628)
226. Resenberger UK, Harmeier A, Woerner AC, Goodman JL, Muller V, Krishnan R, et al. The cellular prion protein mediates neurotoxic signalling of beta-sheet-rich conformers independent of prion replication. EMBO Journal 2011;30(10):2057-70.
227. Raeber AJ, Race RE, Brandner S, Priola SA, Sailer A, Bessen RA, et al. Astrocyte-specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to hamster scrapie. EMBO Journal 1997;16(20):6057-65. (Pubitemid 27458325)
228. Bruce ME. TSE strain variation. British Medical Bulletin 2003;66:99-108. (Pubitemid 37173495)
229. Bessen RA, Marsh RF. Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. Journal of Virology 1992;66(4): 2096-101.
230. Gielbert A, Davis LA, Sayers AR, Hope J, Gill AC, Sauer MJ. High-resolution differentiation of transmissible spongiform encephalopathy strains by quantitative N-terminal amino acid profiling (N-TAAP) of PK-digested abnormal prion protein. Journal of Mass Spectrometry 2009;44(3):384-96.
231. Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Annals of Neurology 1996;39(6):767-78. (Pubitemid 26183813)
232. Schaller O, Fatzer R, Stack M, Clark J, Cooley W, Biffiger K, et al. Validation of a western immunoblotting procedure for bovine PrP(Sc) detection and its use as a rapid surveillance method for the diagnosis of bovine spongiform encephalopathy (BSE). Acta Neuropathologica 1999;98(5):437-43. (Pubitemid 29476160)
233. Somerville RA, Chong A, Mulqueen OU, Birkett CR, Wood SC, Hope J. Biochemical typing of scrapie strains. Nature 1997;386(6625):564.
234. Stack MJ, Chaplin MJ, Clark J. Differentiation of prion protein glycoforms from naturally occurring sheep scrapie, sheep-passaged scrapie strains (CH1641 and SSBP1), bovine spongiform encephalopathy (BSE) cases and Romney and Cheviot breed sheep experimentally inoculated with BSE using two monoclonal antibodies. Acta Neuropathologica 2002;104(3):279-86. (Pubitemid 36075389)
235. Somerville RA, Hamilton S, Fernie K. Transmissible spongiform encephalopathy strain, PrP genotype and brain region all affect the degree of glycosylation of PrPSc. Journal of General Virology 2005;86(Pt 1):241-6. (Pubitemid 40081172)
236. Legname G, Nguyen HO, Peretz D, Cohen FE, De Armond SJ, Prusiner SB. Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proceedings of the National Academy of Sciences of the United States of America 2006;103(50):19105-10. (Pubitemid 350002835)
237. Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M, et al. Eight prion strains have PrP(Sc) molecules with different conformations. Nature Medicine 1998;4(10):1157-65. (Pubitemid 28468829)
238. Caughey B, Raymond GJ, Bessen RA. Strain-dependent differences in beta-sheet conformations of abnormal prion protein. Journal of Biological Chemistry 1998;273(48):32230-5. (Pubitemid 29177169)
239. Baron GS, Hughson AG, Raymond GJ, Offerdahl DK, Barton KA, Raymond LD, et al. Effect of glycans and the glycophosphatidylinositol anchor on strain dependent conformations of scrapie prion protein: improved purifications and infrared spectra. Biochemistry 2011;50(21):4479-90.
240. Fernie K, Steele PJ, Taylor DM, Somerville RA. Comparative studies on the thermostability of five strains of transmissible-spongiform-encephalopathy agent. Biotechnology and Applied Biochemistry 2007;47(Pt 4): 175-83. (Pubitemid 47218251)
241. Peretz D, Scott MR, Groth D, Williamson RA, Burton DR, Cohen FE, et al. Strain-specified relative conformational stability of the scrapie prion protein. Protein Science 2001;10(4):854-63. (Pubitemid 32240511)
242. Castilla J, Morales R, Saa P, Barria M, Gambetti P, Soto C. Cell-free propagation of prion strains. EMBO Journal 2008;27(19):2557-66.
243. Diaz-Avalos R, King CY, Wall J, Simon M, Caspar DL. Strain-specific morphologies of yeast prion amyloid fibrils. Proceedings of the National Academy of Sciences of the United States of America 2005;102(29):10165-70. (Pubitemid 41023343)
244. Tessier PM, Lindquist S. Unraveling infectious structures, strain variants and species barriers for the yeast prion [PSI +]. Nature Structural and Molecular Biology 2009;16(6):598-605.
245. Toyama BH, Kelly MJ, Gross JD, Weissman JS. The structural basis of yeast prion strain variants. Nature 2007;449(7159):233-7. (Pubitemid 47402368)
246. Verges KJ, Smith MH, Toyama BH, Weissman JS. Strain conformation, primary structure and the propagation of the yeast prion [PSI +]. Nature Structural and Molecular Biology 2011;18(4):493-9.
247. Piro JR, Harris BT, Supattapone S. In situ photodegradation of incorporated polyanion does not alter prion infectivity. PLoS Pathogen 2011;7(2):e1002001.
248. Colby DW, Wain R, Baskakov IV, Legname G, Palmer CG, Nguyen HO, et al. Protease-sensitive synthetic prions. PLoS Pathogen 2010;6(1):e1000736.
249. Colby DW, Giles K, Legname G, Wille H, Baskakov IV, De Armond SJ, et al. Design and construction of diverse mammalian prion strains. Proceedings of the National Academy of Sciences of the United States of America 2009;106(48):20417-22.
250. Williams ES, Young S. Chronic wasting disease of captive mule deer: a spongiform encephalopathy. Journal of Wildlife Diseases1980;16(1):89-98.
251. Benestad SL, Sarradin P, Thu B, Schonheit J, Tranulis MA, Bratberg B. Cases of scrapie with unusual features in Norway and designation of a new type, Nor98. Veterinary Record 2003;153(7):202.
252. Seuberlich T, Heim D, Zurbriggen A. Atypical transmissible spongiform encephalopathies in ruminants: a challenge for disease surveillance and control. Journal of Veterinary Diagnostic Investigation 2010;22(6):823-42.
253. Biacabe AG, Laplanche JL, Ryder S, Baron T. Distinct molecular phenotypes in bovine prion diseases. EMBO Reports 2004;5(1):110-4. (Pubitemid 38228537)
254. Casalone C, Zanusso G, Acutis P, Ferrari S, Capucci L, Tagliavini F, et al. Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease. Proceedings of the National Academy of Sciences of the United States of America 2004; 101(9): 3065-70. (Pubitemid 38327735)
255. Seuberlich T, Gsponer M, Drogemuller C, Polak MP, McCutcheon S, Heim D, et al. Novel prion protein in BSE-affected cattle, Switzerland. Emerging Infectious Diseases 2012;18(1):Epub ahead of print.
256. Capobianco R, Casalone C, Suardi S, Mangieri M, Miccolo C, Limido L, et al. Conversion of the BASE prion strain into the BSE strain: the origin of BSE? PLoS Pathogen 2007;3(3):e31.
257. Castilla J, Gonzalez-Romero D, Saa P, Morales R, De Castro J, Soto C. Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions. Cell 2008;134(5):757-68.
258. Kimberlin RH, Cole S, Walker CA. Temporary and permanent modifications to a single strain of mouse scrapie on transmission to rats and hamsters. Journal of General Virology 1987;68(Pt 7):1875-81. (Pubitemid 17120438)
259. Angers RC, Kang HE, Napier D, Browning S, Seward T, Mathiason C, et al. Prion strain mutation determined by prion protein conformational compatibility and primary structure. Science 2010;328(5982):1154-8.
260. Li J, Browning S, Mahal SP, Oelschlegel AM, Weissmann C. Darwinian evolution of prions in cell culture. Science 2010;327(5967):869-72.
261. Ghaemmaghami S, Ahn M, Lessard P, Giles K, Legname G, De Armond SJ, et al. Continuous quinacrine treatment results in the formation of drug-resistant prions. PLoS Pathogen 2009;5(11):e1000673.
262. Bruce ME. Scrapie strain variation and mutation. British Medical Bulletin 1993;49(4):822-38. (Pubitemid 24025991)
263. Collinge J, Clarke AR. A general model of prion strains and their pathogenicity. Science 2007;318(5852):930-6. (Pubitemid 350098981)
264. Bradley R, Wilesmith JW. Epidemiology and control of bovine spongiform encephalopathy (BSE). British Medical Bulletin 1993;49(4):932-59. (Pubitemid 24025996)
265. Saunders SE, Bartelt-Hunt SL, Bartz JC. Prions in the environment: occurrence, fate and mitigation. Prion 2008;2(4):162-9.
266. Wiggins RC. Prion stability and infectivity in the environment. Neurochemical Research 2009;34(1):158-68.
267. Almberg ES, Cross PC, Johnson CJ, Heisey DM, Richards BJ. Modeling routes of chronic wasting disease transmission: environmental prion persistence promotes deer population decline and extinction. PLoS One 2011;6(5): e19896.
268. Gough KC, Maddison BC. Prion transmission: prion excretion and occurrence in the environment. Prion 2010; 4(4):275-82.
269. Nichols TA, Pulford B, Wyckoff AC, Meyerett C, Michel B, Gertig K, et al. Detection of protease-resistant cervid prion protein in water from a CWD-endemic area. Prion 2009;3(3):171-83.
270. Mathiason CK, Hays SA, Powers J, Hayes-Klug J, Langenberg J, Dahmes SJ, et al. Infectious prions in pre-clinical deer and transmission of chronic wasting disease solely by environmental exposure. PLoS One 2009;4(6):e5916.
271. Miller MW, Williams ES, Hobbs NT, Wolfe LL. Environmental sources of prion transmission in mule deer. Emerging Infectious Diseases 2004;10(6):1003-6. (Pubitemid 38697690)
272. Seidel B, Thomzig A, Buschmann A, Groschup MH, Peters R, Beekes M, et al. Scrapie Agent (Strain 263 K) can transmit disease via the oral route after persistence in soil over years. PLoS One 2007;2(5):e435.
273. Seidel B, Thomzig A, Buschmann A, Groschup MH, Peters R, Beekes M, et al. Scrapie agent (Strain 263 K) can transmit disease via the oral route after persistence in soil over years. Plos One 2007;2(5):e435.
274. Haley NJ, Seelig DM, Zabel MD, Telling GC, Hoover EA. Detection of CWD prions in urine and saliva of deer by transgenic mouse bioassay. PLoS One 2009;4(3):e4848.
275. Houston F, Foster JD, Chong A, Hunter N, Bostock CJ. Transmission of BSE by blood transfusion in sheep. Lancet 2000;356(9234):999-1000.
276. Houston F, McCutcheon S, Goldmann W, Chong A, Foster J, Siso S, et al. Prion diseases are efficiently transmitted by blood transfusion in sheep. Blood 2008;112(12):4739-45.
277. Hunter N, Foster J, Chong A, McCutcheon S, Parnham D, Eaton S, et al. Transmission of prion diseases by blood transfusion. Journal of General Virology 2002;83(Pt 11):2897-905. (Pubitemid 35276989)
278. McCutcheon S, Blanco ARA, Houston EF, Wolf CD, Tan BC, Smith A, et al. All clinically-relevant blood components transmit prion disease following a single blood transfusion: a sheep model of vCJD. PLOS One, e23169.
279. Elliott EJ, MacAuley C, D'Addio V, Rohwer RG. Transfusion via the carotid artery in the hamster. Contemporary Topics in Laboratory Animal Science 2005;44(6):28-30. (Pubitemid 41808799)
280. Bons N, Lehmann S, Mestre-Frances N, Dormont D, Brown P. Brain and buffy coat transmission of bovine spongiform encephalopathy to the primate Microcebus murinus. Transfusion 2002;42(5):513-6.
281. Llewelyn CA, Hewitt PE, Knight RS, Amar K, Cousens S, Mackenzie J, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004;363(9407):417-21. (Pubitemid 38210057)
282. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004;364(9433): 527-9. (Pubitemid 39070413)
283. Wroe SJ, Pal S, Siddique D, Hyare H, Macfarlane R, Joiner S, et al. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 2006;368(9552):2061-7. (Pubitemid 44855106)
284. Dickinson AG, Stamp JT, Renwick CC. Maternal and lateral transmission of scrapie in sheep. Journal of Comparative Pathology 1974;84(1):19-25.
285. Hoinville LJ, Tongue SC, Wilesmith JW. Evidence for maternal transmission of scrapie in naturally affected flocks. Preventive Veterinary Medicine 2010;93(2-3):121-8.
286. Foster JD, McKelvey WA, Mylne MJ, Williams A, Hunter N, Hope J, et al. Studies on maternal transmission of scrapie in sheep by embryo transfer. Veterinary Record 1992;130(16):341-3.
287. Wang S, Foote WC, Sutton DL, Maciulis A, Miller JM, Evans RC, et al. Preventing experimental vertical transmission of scrapie by embryo transfer. Theriogenology 2001;56(2):315-27. (Pubitemid 32667326)
288. Andreoletti O, Lacroux C, Chabert A, Monnereau L, Tabouret G, Lantier F, et al. PrP(Sc) accumulation in placentas of ewes exposed to natural scrapie: influence of foetal PrP genotype and effect on ewe-to-lamb transmission. Journal of General Virology 2002; 83(Pt 10):2607-16.
289. Konold T, Moore SJ, Bellworthy SJ, Simmons HA. Evidence of scrapie transmission via milk. BMC Veterinary Research 2008;4:14.
290. Bernoulli C, Siegfried J, Baumgartner G, Regli F, Rabinowicz T, Gajdusek DC, et al. Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet 1977;1(8009):478-9. (Pubitemid 8045134)
291. Davanipour Z, Alter M, Sobel E, Asher D, Gajdusek DC. Creutzfeldt-Jakob disease: possible medical risk factors. Neurology 1985;35(10):1483-6. (Pubitemid 15242428)
292. Duffy P, Wolf J, Collins G, DeVoe AG, Streeten B, Cowen D. Letter: possible person-to-person transmission of Creutzfeldt-Jakob disease. New England Journal of Medicine 1974;290(12):692-3.
293. Masullo C, Pocchiari M, Macchi G, Alema G, Piazza G, Panzera MA. Transmission of Creutzfeldt-Jakob disease by dural cadaveric graft. Journal of Neurosurgery 1989;71(6):954-5. (Pubitemid 20008589)
294. Thadani V, Penar PL, Partington J, Kalb R, Janssen R, Schonberger LB, et al. Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. Case report. Journal of Neurosurgery 1988;69(5):766-9.
295. Fradkin JE, Schonberger LB, Mills JL, Gunn WJ, Piper JM, Wysowski DK, et al. Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States. JAMA 1991;265(7):880-4.
296. Hunter N, Dann JC, Bennett AD, Somerville RA, McConnell I, Hope J. Are Sinc and the PrP gene congruent? Evidence from PrP gene analysis in Sinc congenic mice. Journal of General Virology 1992;73 (Pt 10):2751-5.
297. Hunter N, Hope J, McConnell I, Dickinson AG. Linkage of the scrapie-associated fibril protein (PrP) gene and Sinc using congenic mice and restriction fragment length polymorphism analysis. Journal of General Virology 1987;68 (Pt 10): 2711-6.
298. Moore RC, Hope J, McBride PA, McConnell I, Selfridge J, Melton DW, et al. Mice with gene targetted prion protein alterations show that Prnp, Sinc and Prni are congruent. Nature Genetics 1998;18(2):118-25. (Pubitemid 28082457)
299. Bossers A, Schreuder BE, Muileman IH, Belt PB, Smits MA. PrP genotype contributes to determining survival times of sheep with natural scrapie. Journal of General Virology 1996;77(Pt 10):2669-73. (Pubitemid 26348394)
300. Baylis M, Goldmann W. The genetics of scrapie in sheep and goats. Current Molecular Medicine 2004;4(4): 385-96. (Pubitemid 38787007)
301. Goldmann W, Martin T, Foster J, Hughes S, Smith G, Hughes K, et al. Novel polymorphisms in the caprine PrP gene: a codon 142 mutation associated with scrapie incubation period. Journal of General Virology 1996; 77(Pt 11):2885-91. (Pubitemid 26390592)
302. Goldmann W, Hunter N, Foster JD, Salbaum JM, Beyreuther K, Hope J. Two alleles of a neural protein gene linked to scrapie in sheep. Proceedings of the National Academy of Sciences of the United States of America 1990;87(7): 2476-80.
303. Dawson M, Hoinville LJ, Hosie BD, Hunter N. Guidance on the use of PrP genotyping as an aid to the control of clinical scrapie. Scrapie Information Group. Veterinary Record 1998;142(23):623-5.
304. Goldmann W. PrP genetics in ruminant transmissible spongiform encephalopathies. Veterinary Research 2008;39(4):30.
305. Ortiz-Pelaez A, Bianchini J. The impact of the genotype on the prevalence of classical scrapie at population level. Veterinary Research 2011;42(1):31.
306. Bencsik A, Baron T. Bovine spongiform encephalopathy agent in a prion protein (PrP)ARR/ARR genotype sheep after peripheral challenge: complete immunohistochemical analysis of disease-associated PrP and transmission studies to ovine-transgenic mice. Journal of Infectious Diseases 2007;195(7):989-96. (Pubitemid 46452104)
307. Houston F, Goldmann W, Chong A, Jeffrey M, Gonzalez L, Foster J, et al. Prion diseases: BSE in sheep bred for resistance to infection. Nature 2003;423(6939):498. (Pubitemid 36648568)
308. Groschup MH, Lacroux C, Buschmann A, Luhken G, Mathey J, Eiden M, et al. Classic scrapie in sheep with the ARR/ARR prion genotype in Germany and France. Emerging Infectious Diseases 2007;13(8):1201-7. (Pubitemid 47359165)
309. Foster J, McKenzie C, Parnham D, Drummond D, Goldmann W, Stevenson E, et
310. Georgsson G, Sigurdarson S, Brown P. Infectious agent of sheep scrapie may persist in the environment for at least 16 years. Journal of General Virology 2006;87(Pt 12): 3737-40. (Pubitemid 44817009)
311. Hunter N, Cairns D, Foster JD, Smith G, Goldmann W, Donnelly K. Is scrapie solely a genetic disease? Nature 1997;386(6621):137. (Pubitemid 27131433)
312. Stevens KB, Del Rio Vilas VJ, Guitian J. Classical sheep scrapie in Great Britain: spatial analysis and identification of environmental and farm-related risk factors. BMC Veterinary Research 2009;5:33.
313. del Rio Vilas VJ, Guitian J, Pfeiffer DU, Wilesmith JW. Analysis of data from the passive surveillance of scrapie in Great Britain between 1993 and 2002. Veterinary Record 2006;159(24):799-804. (Pubitemid 46070633)
314. McIntyre KM, Trewby H, Gubbins S, Baylis M. The impact of sheep breed on the risk of classical scrapie. Epidemiology and Infection 2010;138(3):384-92.
315. Goldmann W, Houston F, Stewart P, Perucchini M, Foster J, Hunter N. Ovine prion protein variant A(136)R(154)L(168)Q(171) increases resistance to experimental challenge with bovine spongiform encephalopathy agent. Journal of General Virology 2006;87(Pt 12):3741-5. (Pubitemid 44817010)
316. Vaccari G, D'Agostino C, Nonno R, Rosone F, Conte M, Di Ban MA, et al. Prion protein alleles showing a protective effect on the susceptibility of sheep to scrapie and bovine spongiform encephalopathy. Journal of Virology 2007;81(13):7306-9. (Pubitemid 46986669)
317. Saunders GC, Lantier I, Cawthraw S, Berthon P, Moore SJ, Arnold ME, et al. Protective effect of the T112 PrP variant in sheep challenged with bovine spongiform encephalopathy. Journal of General Virology 2009; 90(Pt 10):2569-74.
318. Benestad SL, Arsac JN, Goldmann W, Noremark M. Atypical/ Nor98 scrapie: properties of the agent, genetics, and epidemiology. Veterinary Research 2008;39(4):19.
319. Le Dur A, Beringue V, Andreoletti O, Reine F, Lai TL, Baron T, et al. A newly identified type of scrapie agent can naturally infect sheep with resistant PrP genotypes. Proceedings of the National Academy of Sciences of the United States of America 2005;102(44):16031-6. (Pubitemid 41552862)
320. Arsac JN, Andreoletti O, Bilheude JM, Lacroux C, Benestad SL, Baron T. Similar biochemical signatures and prion protein genotypes in atypical scrapie and Nor98 cases, France and Norway. Emerging Infectious Diseases 2007;13(1):58-65. (Pubitemid 46057838)
321. Luhken G, Buschmann A, Brandt H, Eiden M, Groschup MH, Erhardt G. Epidemiological and genetical differences between classical and atypical scrapie cases. Veterinary Research 2007;38(1):65-80.
322. Rodriguez-Martinez AB, Garrido JM, Maza S, Benedicto L, Geijo M, Gomez N, et al. Atypical/Nor98 scrapie in the Basque Country: a case report of eight outbreaks. BMC Veterinary Research 2010;6:17.
323. Gilch S, Chitoor N, Taguchi Y, Stuart M, Jewell JE, Schatzl HM. Chronic Wasting Disease. Topics in Current Chemistry 2011;305:51-77.
324. Sigurdson CJ. A prion disease of cervids: chronic wasting disease. Veterinary Research 2008;39(4):41.
325. Vaccari G, Panagiotidis CH, Acin C, Peletto S, Barillet F, Acutis P, et al. State-of-the-art review of goat TSE in the European Union, with special emphasis on PRNP genetics and epidemiology. Veterinary Research 2009;40(5):48.
326. Bouzalas IG, Dovas CI, Banos G, Papanastasopoulou M, Kritas S, Oevermann A, et al. Caprine PRNP polymorphisms at codons 171,211,222 and 240 in a Greek herd and their association with classical scrapie. Journal of General Virology 2010;91(Pt 6):1629-34.
327. Gonzalez L, Martin S, Hawkins SA, Goldmann W, Jeffrey M, Siso S. Pathogenesis of natural goat scrapie: modulation by host PRNP genotype and effect of co-existent conditions. Veterinary Research 2010;41(4):48.
328. Papasavva-Stylianou P, Windl O, Saunders G, Mavrikiou P, Toumazos P, Kakoyiannis C. PrP gene polymorphisms in Cyprus goats and their association with resistance or susceptibility to natural scrapie. Veterinary Journal 2011;187(2):245-50.
329. Perucchini M, Griffin K, Miller MW, Goldmann W. PrP genotypes of free-ranging wapiti (Cervus elaphus nelsoni) with chronic wasting disease. Journal of General Virology 2008;89(Pt 5):1324-8.
330. White SN, Spraker TR, Reynolds JO, O'Rourke KI. Association analysis of PRNP gene region with chronic wasting disease in Rocky Mountain elk. BMC Research Notes 2010;3:314.
331. Wilson GA, Nakada SM, Bollinger TK, Pybus MJ, Merrill EH, Coltman DW. Polymorphisms at the PRNP gene influence susceptibility to chronic wasting disease in two species of deer (Odocoileus spp.) in western Canada. Journal of Toxicology and Environmental Health. Part A 2009; 72(17-18):1025-9.
332. Race R, Raines A, Raymond GJ, Caughey B, Chesebro B. Long-term subclinical carrier state precedes scrapie replication and adaptation in a resistant species: analogies to bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease in humans. Journal of Virology 2001;75(21):10106-12. (Pubitemid 32948040)
333. Dickinson AG, Meikle VM. A comparison of some biological characteristics of the mouse-passaged scrapie agents, 22A and ME7. Genetical Research 1969;13(2): 213-25.
334. Beringue V, Vilotte JL, Laude H. Prion agent diversity and species barrier. Veterinary Research 2008;39(4):47.
335. Scott M, Foster D, Mirenda C, Serban D, Coufal F, Walchli M, et al. Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell 1989;59(5):847-57. (Pubitemid 20022375)
336. Beringue V, Herzog L, Reine F, Le Dur A, Casalone C, Vilotte JL, et al. Transmission of atypical bovine prions to mice transgenic for human prion protein. Emerging Infectious Diseases 2008;14(12):1898-901.
337. Kong Q, Zheng M, Casalone C, Qing L, Huang S, Chakraborty B, et al. Evaluation of the human transmission risk of an atypical bovine spongiform encephalopathy prion strain. Journal of Virology 2008;82(7):3697-701. (Pubitemid 351429945)
338. Padilla D, Beringue V, Espinosa JC, Andreoletti O, Jaumain E, Reine F, et al. Sheep and goat BSE propagate more efficiently than cattle BSE in human PrP transgenic mice. PLoS Pathogen 2011;7(3):e1001319.
339. Barron RM, Baybutt H, Tuzi NL, McCormack J, King D, Moore RC, et al. Polymorphisms at codons 108 and 189 in murine PrP play distinct roles in the control of scrapie incubation time. Journal of General Virology 2005; 86(Pt 3):859-68. (Pubitemid 40331268)
340. Barron RM, Thomson V, Jamieson E, Melton DW, Ironside J, Will R, et al. Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriers. EMBO Journal 2001;20(18):5070-8. (Pubitemid 32910903)
341. Bishop MT, Hart P, Aitchison L, Baybutt HN, Plinston C, Thomson V, et al. Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurology 2006;5(5):393-8.
342. Kaneko K, Zulianello L, Scott M, Cooper CM, Wallace AC, James TL, et al. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proceedings of the National Academy of Sciences of the United States of America 1997;94(19):10069-74.
343. Gorfe AA, Caflisch A. Serl 70 controls the conformational multiplicity of the loop 166-175 in prion proteins: implication for conversion and species barrier. FASEB Journal 2007;21(12):3279-87. (Pubitemid 47565546)
344. Meli M, Gasset M, Colombo G. Dynamic diagnosis of familial prion diseases supports the beta2-alpha2 loop as a universal interference target. PLoS One 2011;6(4):e19093.
345. Sigurdson CJ, Nilsson KP, Hornemann S, Heikenwalder M, Manco G, Schwarz P, et al. De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis. Proceedings of the National Academy of Sciences of the United States of America 2009;106(1): 304-9.
346. Sigurdson CJ, Nilsson KP, Hornemann S, Manco G, Fernandez-Borges N, Schwarz P, et al. A molecular switch controls interspecies prion disease transmission in mice. Journal of Clinical Investigation 2010;120(7):2590-9.
347. Wen Y, Li J, Yao W, Xiong M, Hong J, Peng Y, et al. Unique structural characteristics of the rabbit prion protein. Journal of Biological Chemistry 2010;285(41): 31682-93.
348. van Keulen LJ, Bossers A, van Zijderveld F. TSE pathogenesis in cattle and sheep. Veterinary Research 2008;39(4):24.
349. van Keulen LJ, Vromans ME, Dolstra CH, Bossers A, van Zijderveld FG. Pathogenesis of bovine spongiform encephalopathy in sheep. Archives of Virology 2008;153(3):445-53.
350. Hilton DA. Pathogenesis and prevalence of variant Creutzfeldt-Jakob disease. Journal of Pathology 2006;208(2):134-41. (Pubitemid 43126107)
351. Masujin K, Matthews D, Wells GA, Mohri S, Yokoyama T. Prions in the peripheral nerves of bovine spongiform encephalopathy-affected cattle. Journal of General Virology 2007;88(Pt 6):1850-8. (Pubitemid 46845991)
352. Arnold ME, Hawkins SA, Green R, Dexter I, Wells GA. Pathogenesis of experimental bovine spongiform encephalopathy (BSE): estimation of tissue infectivity according to incubation period. Veterinary Research 2009;40(1):8.
353. Beekes M, McBride PA. The spread of prions through the body in naturally acquired transmissible spongiform encephalopathies. FEBS Journal 2007;274(3):588-605. (Pubitemid 46150854)
354. Aguzzi A, Calella AM. Prions: protein aggregation and infectious diseases. Physiological Reviews 2009;89(4): 1105-52.
355. Blatt ler T. Transmission of prion disease. APMIS 2002;110(1):71-8.
356. Mabbott NA, MacPherson GG. Prions and their lethal journey to the brain. Nature Reviews, Microbiology 2006;4(3): 201-11.
357. Heppner FL, Christ AD, Klein MA, Prinz M, Fried M, Kraehenbuhl JP, et al. Transepithelial prion transport by M cells. Nature Medicine 2001;7(9):976-7.
358. Huang FP, Farquhar CF, Mabbott NA, Bruce ME, MacPherson GG. Migrating intestinal dendritic cells transport PrP(Sc) from the gut. Journal of General Virology 2002; 83(Pt 1):267-71. (Pubitemid 34030831)
359. Miyazawa K, Kanaya T, Takakura I, Tanaka S, Hondo T, Watanabe H, et al. Transcytosis of murine-adapted bovine spongiform encephalopathy agents in an in vitro bovine M cell model. Journal of Virology 2010;84(23):12285-91.
360. Raymond CR, Aucouturier P, Mabbott NA. In vivo depletion of CD11c+ cells impairs scrapie agent neuroinvasion from the intestine. Journal of Immunology 2007;179(11):7758-66.
361. Raymond CR, Mabbott NA. Assessing the involvement of migratory dendritic cells in the transfer of the scrapie agent from the immune to peripheral nervous systems. Journal of Neuroimmunology 2007;187(1-2):114-25. (Pubitemid 47001552)
362. Brown KL, Stewart K, Ritchie DL, Mabbott NA, Williams A, Fraser H, et al. Scrapie replication in lymphoid tissues depends on prion protein-expressing follicular dendritic cells. Nature Medicine 1999;5(11):1308-12. (Pubitemid 29535610)
363. Mabbott NA, Mackay F, Minns F, Bruce ME. Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie. Nature Medicine 2000;6(7):719-20. (Pubitemid 30469392)
364. Mabbott NA, McGovern G, Jeffrey M, Bruce ME. Temporary blockade of the tumor necrosis factor receptor signaling pathway impedes the spread of scrapie to the brain. Journal of Virology 2002;76(10):5131-9. (Pubitemid 34441717)
365. Mabbott NA, Young J, McConnell I, Bruce ME. Follicular dendritic cell dedifferentiation by treatment with an inhibitor of the lymphotoxin pathway dramatically reduces scrapie susceptibility. Journal of Virology 2003;77(12): 6845-54. (Pubitemid 36666878)
366. Blattler T, Brandner S, Raeber AJ, Klein MA, Voigtlander T, Weissmann C, et al. PrP-expressing tissue required for transfer of scrapie infectivity from spleen to brain. Nature 1997;389(6646):69-73. (Pubitemid 27387692)
367. Klein MA, Frigg R, Flechsig E, Raeber AJ, Kalinke U, Bluethmann H, et al. A crucial role for B cells in neuroinvasive scrapie. Nature 1997;390(6661):687-90. (Pubitemid 28016356)
368. Klein MA, Kaeser PS, Schwarz P, Weyd H, Xenarios I, Zinkernagel RM, et al. Complement facilitates early prion pathogenesis. Nature Medicine 2001;7(4):488-92. (Pubitemid 32298554)
369. Lasmezas CI, Cesbron JY, Deslys JP, Demaimay R, Adjou KT, Rioux R, et al. Immune system-dependent and -independent replication of the scrapie agent. Journal of Virology 1996;70(2):1292-5. (Pubitemid 26029059)
370. Mabbott NA, Bruce ME, Botto M, Walport MJ, Pepys MB. Temporary depletion of complement component C3 or genetic deficiency of Cl q significantly delays onset of scrapie. Nature Medicine 2001;7(4):485-7. (Pubitemid 32298553)
371. O'Rourke KI, Huff TP, Leathers CW, Robinson MM, Gorham JR. SCID mouse spleen does not support scrapie agent replication. Journal of General Virology 1994; 75(Pt 6):1511-4. (Pubitemid 24174072)
372. Sigurdson CJ, Heikenwalder M, Manco G, Barthel M, Schwarz P, Stecher B, et al. Bacterial colitis increases susceptibility to oral prion disease. Journal of Infectious Diseases 2009;199(2):243-52.
373. Brown KL, Wathne GJ, Sales J, Bruce ME, Mabbott NA. The effects of host age on follicular dendritic cell status dramatically impair scrapie agent neuroinvasion in aged mice. Journal of Immunology 2009;183(8):5199-207.
374. Kimberlin RH, Walker CA. Pathogenesis of scrapie in mice after intragastric infection. Virus Research 1989;12(3): 213-20. (Pubitemid 19088147)
375. McBride PA, Beekes M. Pathological PrP is abundant in sympathetic and sensory ganglia of hamsters fed with scrapie. Neuroscience Letters 1999;265(2):135-8. (Pubitemid 29210387)
376. McBride PA, Schulz-Schaeffer WJ, Donaldson M, Bruce M, Diringer H, Kretzschmar HA, et al. Early spread of scrapie from the gastrointestinal tract to the central nervous system involves autonomic fibers of the splanchnic and vagus nerves. Journal of Virology 2001; 75(19):9320-7. (Pubitemid 32851936)
377. Dorban G, Defaweux V, Heinen E, Antoine N. Spreading of prions from the immune to the peripheral nervous system: a potential implication of dendritic cells. Histochemistry and Cell Biology 2010;133(5):493-504.
378. Fevrier B, Vilette D, Archer F, Loew D, Faigle W, Vidal M, et al. Cells release prions in association with exosomes. Proceedings of the National Academy of Sciences of the United States of America 2004;101(26):9683-8. (Pubitemid 38869296)
379. Langevin C, Gousset K, Costanzo M, Richard-Le Goff O, Zurzolo C. Characterization of the role of dendritic cells in prion transfer to primary neurons. Biochemical Journal 2010;431(2):189-98.
380. Vella LJ, Sharpies RA, Lawson VA, Masters CL, Cappai R, Hill AF. Packaging of prions into exosomes is associated with a novel pathway of PrP processing. Journal of Pathology 2007;211(5):582-90. (Pubitemid 46502435)
381. Kanu N, Imokawa Y, Drechsel DN, Williamson RA, Birkett CR, Bostock CJ, et al. Transfer of scrapie prion infectivity by cell contact in culture. Current Biology 2002;12(7):523-30. (Pubitemid 34271365)
382. Gousset K, Schiff E, Langevin C, Marijanovic Z, Caputo A, Browman DT, et al. Prions hijack tunnelling nanotubes for intercellular spread. Nature Cell Biology 2009;11(3): 328-36.
383. Haik S, Faucheux BA, Sazdovitch V, Privat N, Kemeny JL, Perret-Liaudet A, et al. The sympathetic nervous system is involved in variant Creutzfeldt-Jakob disease. Nature Medicine 2003;9(9):1121-3. (Pubitemid 37173693)
384. Glatzel M, Heppner FL, Albers KM, Aguzzi A. Sympathetic innervation of lymphoreticular organs is rate limiting for prion neuroinvasion. Neuron 2001;31(1):25-34. (Pubitemid 32757086)
385. Glatzel M, Aguzzi A. PrP(C) expression in the peripheral nervous system is a determinant of prion neuroinvasion. Journal of General Virology 2000;81(Pt 11):2813-21.
386. Banks WA, Niehoff ML, Adessi C, Soto C. Passage of murine scrapie prion protein across the mouse vascular blood-brain barrier. Biochemical and Biophysical Research Communications 2004;318(1):125-30. (Pubitemid 38526254)
387. Banks WA, Robinson SM, Diaz-Espinoza R, Urayama A, Soto C. Transport of prion protein across the blood-brain barrier. Experimental Neurology 2009;218(1):162-7.
388. Siso S, Gonzalez L, Jeffrey M. Neuroinvasion in prion diseases: the roles of ascending neural infection and blood dissemination. Interdisciplinary Perspective on Infections Diseases 2010;2010:747892.
389. Edgeworth JA, Farmer M, Sicilia A, Tavares P, Beck J, Campbell T, et al. Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay. Lancet 2011;377(9764):487-93.
390. Tattum MH, Jones S, Pal S, Khalili-Shirazi A, Collinge J, Jackson GS. A highly sensitive immunoassay for the detection of prion-infected material in whole human blood without the use of proteinase K. Transfusion 2010;50(12):2619-27.
391. Gonzalez-Montalban N, Makarava N, Ostapchenko VG, Savtchenk R, Alexeeva I, Rohwer RG, et al. Highly efficient protein misfolding cyclic amplification. PLoS Pathogen 2011;7(2):e1001277.
392. Jones M, Peden AH, Head MW, Ironside JW. The application of in vitro cell-free conversion systems to human prion diseases. Acta Neuropathologica 2011;121(1):135-43.
393. Tattum MH, Jones S, Pal S, Collinge J, Jackson GS. Discrimination between prion-infected and normal blood samples by protein misfolding cyclic amplification. Transfusion 2010;50(5):996-1002.
394. Terry LA, Howells L, Bishop K, Baker CA, Everest S, Thorne L, et al. Detection of prions in the faeces of sheep naturally infected with classical scrapie. Veterinary Research 2011;42(1):65.
395. Atarashi R, Satoh K, Sano K, Fuse T, Yamaguchi N, Ishibashi D, et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nature Medicine 2011;17(2):175-8.
396. Orru CD, Wilham JM, Raymond LD, Kuhn F, Schroeder B, Raeber AJ, et al. Prion disease blood test using immunoprecipitation and improved quaking-induced conversion. mBio 2011;2(3):EO0078-11.
397. Wilham JM, Orru CD, Bessen RA, Atarashi R, Sano K, Race B, et al. Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays. PLoS Pathogen 2010;6(12):e1001217.
398. Klohn PC, Stoltze L, Flechsig E, Enari M, Weissmann C. A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions. Proceedings of the National Academy of Sciences of the United States of America 2003;100(20):11666-71. (Pubitemid 37205992)
399. Karapetyan YE, Saa P, Mahal SP, Sferrazza GF, Sherman A, Sales N, et al. Prion strain discrimination based on rapid in vivo amplification and analysis by the cell panel assay. PLoS One 2009;4(5):e5730.
400. Mahal SP, Demczyk CA, Smith Jr EW, Klohn PC, Weissmann C. Assaying prions in cell culture: the standard scrapie cell assay (SSCA) and the scrapie cell assay in end point format (SCEPA). Methods in Molecular Biology 2008;459:49-68.
401. Gonzalez L, Jeffrey M, Siso S, Martin S, Bellworthy SJ, Stack MJ, et al. Diagnosis of preclinical scrapie in samples of rectal mucosa. Veterinary Record 2005;156(26):846-7. (Pubitemid 40933027)
402. Dennis MM, Thomsen BV, Marshall KL, Hall SM, Wagner BA, Salman MD, et al. Evaluation of immunohistochemical detection of prion protein in rectoanal mucosa-associated lymphoid tissue for diagnosis of scrapie in sheep. American Journal of Veterinary Research 2009;70(1):63-72.
403. Espenes A, Press CM, Landsverk T, Tranulis MA, Aleksandersen M, Gunnes G, et al. Detection of PrP(Sc) in rectal biopsy and necropsy samples from sheep with experimental scrapie. Journal of Comparative Pathology 2006;134(2-3):115- 25.
404. Keane D, Barr D, Osborn R, Langenberg J, O'Rourke K, Schneider D, et al. Validation of use of rectoanal mucosaassociated lymphoid tissue for immunohistochemical diagnosis of chronic wasting disease in white-tailed deer (Odocoileus virginianus). Journal of Clinical Microbiology 2009;47(5):1412-7.
405. Spraker TR, Vercauteren KC, Gidlewski T, Schneider DA, Munger R, Balachandran A, et al. Antemortem detection of PrPCWD in preclinical, ranch-raised Rocky Mountain elk (Genius elaphus nelson') by biopsy of the rectal mucosa. Journal of Veterinary Diagnostic Investigation 2009;21(1): 15-24.
406. Brown P. An historical perspective on efforts to treat transmissible spongiform encephalopathy. CNS and Neurological Disorders - Drug Targets 2009;8(5):316-22.
407. Ai Tran HN, Sousa F, Moda F, Mandal S, Chanana M, Vimercati C, et al. A novel class of potential prion drugs: preliminary in vitro and in vivo data for multilayer coated gold nanoparticles. Nanoscale 2010;2(12):2724-32.
408. Bolognesi ML, Ai Tran HN, Staderini M, Monaco A, Lopez-Cobenas A, Bongarzone S, et al. Discovery of a class of diketopiperazines as antiprion compounds. ChemMedChem 2010;5(8):1324-34.
409. Gallardo-Godoy A, Geyer J, Fife KL, Silber BM, Prusiner SB, Rens lo AR. 2-Aminothiazoles as therapeutic leads for prion diseases. Journal of Medicinal Chemistry 2011;54(4): 1010-21.
410. Geissen M, Leidel F, Eiden M, Hirschberger T, Fast C, Bertsch U, et al. From high-throughput cell culture screening to mouse model: identification of new inhibitor classes against prion disease. ChemMedChem 2011;6(10): 1928-37.
411. Lim YB, Mays CE, Kim Y, Titlow WB, Ryou C. The inhibition of prions through blocking prion conversion by permanently charged branched polyamines of low cytotoxicity. Biomaterials 2010;31(8):2025-33.
412. Supattapone S, Piro JR, Rees JR. Complex polyamines: unique prion disaggregating compounds. CNS and Neurological Disorders - Drug Targets 2009;8(5):323-8.
413. Thompson MJ, Louth JC, Ferrara S, Sorrell FJ, Irving BJ, Cochrane EJ, et al. Structure-activity relationship refinement and further assessment of indole-3-glyoxylamides as a lead series against prion disease. ChemMedChem 2011;6(1):115-30.
414. Sim VL, Caughey B. Recent advances in prion chemotherapeutics. Infectious Disorders - Drug Targets 2009;9(1):81-91.
415. Farquhar C, Dickinson A, Bruce M. Prophylactic potential of pentosan polysulphate in transmissible spongiform encephalopathies. Lancet 1999;353(9147):117. (Pubitemid 29088083)
416. Todd NV, Morrow J, Doh-ura K, Dealler S, O'Hare S, Farling P, et al. Cerebroventricular infusion of pentosan polysulphate in human variant Creutzfeldt-Jakob disease. Journal of Infection 2005;50(5):394-6. (Pubitemid 40692023)
417. Enari M, Flechsig E, Weissmann C. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proceedings of the National Academy of Sciences of the United States of America 2001;98(16):9295-9. (Pubitemid 32743910)
418. Peretz D, Williamson RA, Kaneko K, Vergara J, Leclerc E, Schmitt-Ulms G, et al. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 2001;412(6848):739-43. (Pubitemid 32771997)
419. Heppner FL, Musahl C, Arrighi I, Klein MA, Rulicke T, Desch B, et al. Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies. Science 2001;294(5540):178-82. (Pubitemid 32952973)
420. Polymenidou M, Heppner FL, Pellicioli EC, Urich E, Miele G, Braun N, et al. Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection. Proceedings of the National Academy of Sciences of the United States of America 2004;101 Suppl. 2:14670-6. (Pubitemid 39346741)
421. Sigurdsson EM, Brown DR, Daniels M, Kascsak RJ, Kascsak R, Carp R, et al. Immunization delays the onset of prion disease in mice. American Journal of Pathology 2002;161(1):13-7. (Pubitemid 34760765)
422. White AR, Enever P, Tayebi M, Mushens R, Linehan J, Brandner S, et al. Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 2003;422(6927):80-3. (Pubitemid 36323299)
423. Solforosi L, Criado JR, McGavern DB, Wirz S, Sanchez-Alavez M, Sugama S, et al. Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 2004;303(5663):1514-6. (Pubitemid 38314420)
424. Korth C, Stierli B, Streit P, Moser M, Schaller O, Fischer R, et al. Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature 1997;390(6655):74-7. (Pubitemid 27494758)
425. Moroncini G, Kanu N, Solforosi L, Abalos G, Telling GC, Head M, et al. Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrP(Sc). Proceedings of the National Academy of Sciences of the United States of America 2004;101(28):10404-9. (Pubitemid 38924938)
426. Moroncini G, Mangieri M, Morbin M, Mazzoleni G, Ghetti B, Gabrielli A, et al. Pathologic prion protein is specifically recognized in situ by a novel PrP conformational antibody. Neurobiology of Disease 2006;23(3):717-24. (Pubitemid 44234107)
427. Paramithiotis E, Pinard M, Lawton T, LaBoissiere S, Leathers VL, Zou WQ, et al. A prion protein epitope selective for the pathologically misfolded conformation. Nature Medicine 2003;9(7):893-9. (Pubitemid 36889932)
428. Solforosi L, Belton A, Schaller M, Cruite JT, Abalos GC, Williamson RA. Toward molecular dissection of PrPC-PrPSc interactions. Journal of Biological Chemistry 2007;282(10):7465-71. (Pubitemid 47093641)
429. Tayebi M, Jones DR, Taylor WA, Stileman BF, Chapman C, Zhao DM, et al. PrP(Sc)-specific antibodies with the ability to immunodetect prion oligomers. PLoS One 2011;6(5):e19998.
430. Skrlj N, Vranac T, Popovic M, Serbec VC, Dolinar M. Specific binding of the pathogenic prion isoform: development and characterization of a humanized single-chain variable antibody fragment. PLoS One 2011;6(1):e15783.
431. Petsch B, Muller-Schiffmann A, Leh le A, Zirdum E, Prikulis I, Kuhn F, et al. Biological effects and use of PrP(Sc)- and PrP-specific antibodies generated by immunization with purified full-length native mouse prions. Journal of Virology 2011;85(9):4538-46.
432. Goni F, Prelli F, Ji Y, Scholtzova H, Yang J, Sun YJ, et al. Immunomodulation targeting abnormal protein conformation reduces pathology in a mouse model of Alzheimer's disease. PLoS One 2010;5(10):e13391.
433. Roskam S, Neff F, Schwarting R, Bacher M, Dodel R. APP transgenic mice: the effect of active and passive immunotherapy in cognitive tasks. Neuroscience and Biobehavioral Reviews 2010;34(4):487-99.
434. Lord A, Gumucio A, Englund H, Sehlin D, Sundquist VS, Soderberg L, et al. An amyloid-beta protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease. Neurobiology of Disease 2009;36(3):425-34.
435. Wang XP, Zhang JH, Wang YJ, Feng Y, Zhang X, Sun XX, et al. Conformation-dependent single-chain variable fragment antibodies specifically recognize beta-amyloid oligomers. FEBS Letters 2009;583(3):579-84.
436. Lafaye P, Achour I, England P, Duyckaerts C, Rougeon F. Single-domain antibodies recognize selectively small oligomeric forms of amyloid beta, prevent A beta-induced neurotoxicity and inhibit fibril formation. Molecular Immunology 2009;46(4):695-704.
437. Lee EB, Leng LZ, Zhang B, Kwong L, Trojanowski JQ, Abel T, et al. Targeting amyloid-beta peptide (A beta) oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in A beta precursor protein (APP) transgenic mice. Journal of Biological Chemistry 2006;281(7):4292-9. (Pubitemid 43847859)
438. Moretto N, Bolchi A, Rivetti C, Imbimbo BP, Villetti G, Pietrini V, et al. Conformation-sensitive antibodies against Alzheimer amyloid-beta by immunization with a thioredoxin-constrained B-cell epitope peptide. Journal of Biological Chemistry 2007;282(15):11436-45. (Pubitemid 47100761)
439. Bolmont T, Clavaguera F, Meyer-Luehmann M, Herzig MC, Radde R, Staufenbiel M, et al. Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APPx Tau transgenic mice. American Journal of Pathology 2007;171(6):2012-20.
440. Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, Crews L, et al. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proceedings of the National Academy of Sciences of the United States of America 2009;106(31):13010-5.
441. Eisele YS, Bolmont T, Heikenwalder M, Langer F, Jacobson LH, Yan ZX, et al. Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation. Proceedings of the National Academy of Sciences of the United States of America 2009;106(31):12926-31.
442. Guo JL, Lee VM. Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles. Journal of Biological Chemistry 2011;286(17): 15317-31.
443. Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nature Medicine 2008;14(5):504-6. (Pubitemid 351655212)
444. Krammer C, Schatzl HM, Vorberg I. Prion-like propagation of cytosolic protein aggregates: insights from cell culture models. Prion 2009;3(4):206-12.
445. Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, et al. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nature Medicine 2008;14(5):501-3. (Pubitemid 351655211)
446. Lundmark K, Westermark GT, Nystrom S, Murphy CL, Solomon A, Westermark P. Transmissibility of systemic amyloidosis by a prion-like mechanism. Proceedings of the National Academy of Sciences of the United States of America 2002;99(10):6979-84. (Pubitemid 34526243)
447. Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, et al. Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 2006;313(5794):1781-4. (Pubitemid 44454153)
448. Munch C, O'Brien J, Bertolotti A. Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proceedings of the National Academy of Sciences of the United States of America 2011;108(9): 3548-53.
449. Sydow A, Mandelkow EM. 'Prion-like' propagation of mouse and human tau aggregates in an inducible mouse model of tauopathy. Neurodegenerative Disorders 2010;7(1-3):28-31.
450. Grad LI, Guest WC, Yanai A, Pokrishevsky E, O'Neill MA, Gibbs E, et al. Intermolecular transmission of superoxide dismutase 1 misfolding in living cells. Proceedings of the National Academy of Sciences of the United States of America 2011;108(39):16398-403.
451. Frost B, Diamond MI. Prion-like mechanisms in neurodegenerative diseases. Nature Reviews, Neuroscience 2010;11(3):155-9.
452. Kayed R, Canto I, Breydo L, Rasool S, Lukacsovich T, Wu J, et al. Conformation dependent monoclonal antibodies distinguish different replicating strains or conformers of prefibrillar Abeta oligomers. Molecular Neurodegeneration 2010;5:57.
453. Petkova AT, Leapman RD, Guo Z, Yau WM, Mattson MP, Tycko R. Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. Science 2005;307(5707):262-5. (Pubitemid 40116242)
454. Yonetani M, Nonaka T, Masuda M, Inukai Y, Oikawa T, Hisanaga S, et al. Conversion of wild-type alpha-synuclein into mutant-type fibrils and its propagation in the presence of A3OP mutant. Journal of Biological Chemistry 2009;284(12):7940-50.
455. Heinrich SU, Lindquist S. Protein-only mechanism induces self-perpetuating changes in the activity of neuronal Aplysia cytoplasmic polyadenylation element binding protein (CPEB). Proceedings of the National Academy of Sciences of the United States of America 2011;108(7): 2999-3004.
456. Maury CP. Self-propagating beta-sheet polypeptide structures as prebiotic informational molecular entities: the amyloid world. Origins of Life and Evolution of the Biosphere 2009;39(2):141-50.
457. Pedersen JS, Dikov D, Flink JL, Hjuler HA, Christiansen G, Otzen DE. The changing face of glucagon fibrillation: structural polymorphism and conformational imprinting. Journal of Molecular Biology 2006;355(3):501-23. (Pubitemid 41785753)
458. Baylis M, Goldmann W. The genetics of scrapie in sheep and goats. Current Molecular Medicine 2004;4(4):385-96. (Pubitemid 38787007)
459. Baylis M, Chihota C, Stevenson E, Goldmann W, Smith A, Sivam K, et al. Risk of scrapie in British sheep of different prion protein genotype. Journal of General Virology 2004;85:2735-40. (Pubitemid 39214368)